discontinue sulfonylurea when starting glp-1 receptor agonist should I stop gliclazide (sulfonylurea) in a patient with controlled blood glucose levels on Ozempic (semaglutide), linagliptin (DPP-4 inhibitor), and metformin (biguanide)? A Closer Look at the

The impact of peri-operative anti-TNF treatment on anastomosis-related complications in Crohns disease patients

Lancet Diabetes Endocrinol 6(8):605617 [DOI] [PubMed] [Google Scholar] Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018b) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

Am J health-system pharmacy: AJHP: Off J Am Soc Health-System Pharmacists

G.ApteM.BanksP

Increased lipase and alanine aminotransferase were noted in 3 (23.1%) and 1 (7.7%) of the patients, respectively, with none of those resulting in pancreatitis and/or cholelithiasis

Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway